The Georgia Life Sciences Summit has grown into a must-attend event for Georgia’s bioscience and medtech communities. The Summit provides a forum for professionals from industry, academia, and government to discuss major trends and issues, including topics related to scientific research, product development, financing, business development, and public policy. It is the one time each year companies and universities can showcase Georgia’s bioscience innovation.
Wayne Elowe, Co-Chair, Life Sciences, Medical Technology Group, and Corporate Practice will be apart of the panel discussion From Policy to Pitch: What Investors Want in Today’s Life Sciences Landscape. This session will begin with a fireside chat featuring John Guy, Policy Director at Incubate Coalition, who will share insights from recent investor surveys and conversations examining the policy issues most influencing life sciences investment decisions today. Building on these insights, the session will transition into a discussion with venture capital leaders on how emerging companies can effectively address these concerns in their fundraising strategy and investor messaging. From regulatory pathways, drug pricing, and Most Favored Nation (MFN) policies to federal funding priorities, FDA stability, and global competitiveness, the conversation will explore how policy uncertainty and market dynamics are shaping capital allocation across the sector.